09/20/2023 / By Ethan Huff
Despite one of its lawyers recently admitting in court that Americans can, in fact, take ivermectin as a Wuhan coronavirus (COVID-19) treatment, the U.S. Food and Drug Administration (FDA) is still refusing to change its official stance concerning the prophylactic drug.
Even though a court ruled that the FDA acted well outside of its jurisdictional authority with the whole “horse paste” fiasco, the FDA says it will not change any of its past statements against ivermectin.
A U.S. appeals court ruled that these past statements from the FDA, including one on Twitter (now X) telling the public to “stop” using ivermectin because it is supposedly just for barnyard animals, went beyond the authority conferred on the agency by Congress. And yet, the FDA is still digging its heels in the sand.
“FDA can inform, but it has identified no authority allowing it to recommend consumers ‘stop’ taking medicine,” ruled U.S. Circuit Judge Don Willett in a September 1 ruling.
(Related: A quick fact check shows that the FDA first approved ivermectin for human use back in 1996.)
It has been about two weeks since Judge Willett’s ruling, and the social media post in question, as well as others, is still up on X unchanged.
“You are not a horse,” reads the Aug. 21, 2021, X post that got the FDA in trouble in the first place. “You are not a cow. Seriously, y’all. Stop it.”
The webpage that the FDA linked to in this particular social media post also remains unchanged, ordering Americans that they “should not use ivermectin to treat or prevent COVID-19.”
To be fair, the appeals court never actually told the FDA to modify or take down the posts. The case has also been remanded to a lower court for consideration on its standing.
Still, Dr. Robert Apter, the lead plaintiff in the case that ultimately led to Willett’s ruling, says the FDA has an obligation to take down these offending posts that are still up in violation of the law.
“From an ethical point of view, the FDA has been told not to do what they are doing,” Dr. Apter is quoted as saying. “They have an ethical and moral obligation to follow the court’s directive and stop giving advice against using effective repurposed drugs for early treatment of COVID.”
When asked by at least one independent media outlet for comment on the matter, the FDA reportedly declined.
The FDA did, however, issue a statement following Judge Willett’s ruling. It states that ivermectin is approved by the agency for other uses, but not for COVID, even though Big Pharma companies have been repurposing FDA-approved drugs for decades without consequence.
The FDA stipulated that it “has not authorized or approved ivermectin for use in preventing or treating COVID-19, nor has the agency stated that it is safe or effective for that use.”
“Health care professionals generally may choose to prescribe an approved human drug for an unapproved use when they judge that the unapproved use is medically appropriate for an individual patient,” the agency added.
This process is known as off-label prescription, and it is common in the United States as drug companies look for new ways to keep the profits flowing once a given drug loses its luster for its officially approved purpose.
“The decision is pretty clear that the FDA is not a physician, and that while it might have authority to inform the public, it can’t endorse particular treatments or advise on how to approach any specific illness,” commented Jared Kelson, an attorney representing the doctor plaintiffs in the case.
The latest news about the corrupt and criminally run FDA can be found at FDA.news.
Sources for this article include:
Tagged Under:
alternative medicine, big government, conspiracy, corruption, court, COVID, covid-19, deception, FDA, Food and Drug Administration, health freedom, infections, ivermectin, medical censorship, medical fascism, Medical Tyranny, outbreak, pandemic, traitors
This article may contain statements that reflect the opinion of the author
PharmaceuticalFraud.com is a fact-based public education website published by Pharmaceutical Fraud Features, LLC.
All content copyright © 2018 by Pharmaceutical Fraud Features, LLC.
Contact Us with Tips or Corrections
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.